Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · IEX Real-Time Price · USD

49.57

+0.31 (0.63%)

At close: Jul 19, 2024, 4:00 PM

49.55

-0.02 (-0.04%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Rhythm Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Revenue	91.93	77.43	23.64	3.15	0	0	Upgrade
Revenue Growth (YoY)	173.52%	227.56%	649.46%	-	-	-	Upgrade
Cost of Revenue	10.69	9.3	2.13	0.6	0	0	Upgrade
Gross Profit	81.24	68.13	21.51	2.56	0	0	Upgrade
Selling, General & Admin	127.28	117.53	92.03	68.49	46.13	36.55	Upgrade
Research & Development	225.67	134.95	108.63	104.13	90.45	109.45	Upgrade
Operating Expenses	352.95	252.48	200.66	172.61	136.58	146	Upgrade
Operating Income	-271.71	-184.36	-179.16	-170.06	-136.58	-146	Upgrade
Interest Expense / Income	15.76	13.89	5.2	0	0	0	Upgrade
Other Expense / Income	-14.46	-14.14	-3.24	-100.45	-2.58	-5.27	Upgrade
Pretax Income	-273.01	-184.11	-181.12	-69.61	-134	-140.73	Upgrade
Income Tax	0.86	0.56	0	0	0	0	Upgrade
Net Income	-273.87	-184.68	-181.12	-69.61	-134	-140.73	Upgrade
Shares Outstanding (Basic)	60	58	52	50	44	36	Upgrade
Shares Outstanding (Diluted)	60	58	52	50	44	36	Upgrade
Shares Change	6.06%	10.65%	5.08%	12.40%	21.15%	17.48%	Upgrade
EPS (Basic)	-4.63	-3.20	-3.47	-1.40	-3.04	-3.86	Upgrade
EPS (Diluted)	-4.63	-3.20	-3.47	-1.40	-3.04	-3.86	Upgrade
Free Cash Flow	-140.47	-136.2	-173.71	-46.44	-122.19	-126.14	Upgrade
Free Cash Flow Per Share	-2.34	-2.36	-3.33	-0.94	-2.77	-3.46	Upgrade
Gross Margin	88.37%	87.99%	90.98%	81.01%	-	-	Upgrade
Operating Margin	-295.57%	-238.10%	-757.92%	-5391.85%	-	-	Upgrade
Profit Margin	-297.93%	-238.52%	-766.22%	-2207.10%	-	-	Upgrade
Free Cash Flow Margin	-152.80%	-175.91%	-734.87%	-1472.32%	-	-	Upgrade
EBITDA	-255.54	-168.46	-174.25	-68.45	-133.31	-139.9	Upgrade
EBITDA Margin	-277.99%	-217.58%	-737.14%	-2170.39%	-	-	Upgrade
Depreciation & Amortization	1.71	1.76	1.67	1.16	0.69	0.83	Upgrade
EBIT	-257.25	-170.22	-175.92	-69.61	-134	-140.73	Upgrade
EBIT Margin	-279.84%	-219.85%	-744.22%	-2207.10%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).